At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Whey protein-enriched milk fat globule membrane supplement (supplement), Whey protein-based supplement (supplement)
- How long the study runs
- Study runs about 13 months (dates as stated)
- About the drug or intervention
- Whey protein-enriched milk fat globule membrane supplement — supplement: Participants will consume a high-fat, mixed meal containing approximately 75 g of test fat (refined palm oil), supplemented with a whey protein-enriched milk fat globule membrane (providing \~5 g of milk polar lipids) powdered ingredient. · Whey protein-based supplement — supplement: Participants will consume a high-fat, mixed meal containing approximately 75 g of test fat (refined palm oil) supplemented with a whey protein-based powdered ingredient without milk fat globule membrane (placebo) The experimental and placebo meals will be isoenergetic and protein-matched, and will be administered in a randomised order, with a washout period of at least 21 days between sessions.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 50 Years to 75 Years
- Who
- Female
- Number of participants
- 16
- Started
- 2025-09-30
- Last checked
- 2026-05
Plain English Summary
What is this study?
- • Testing a new treatment for cardiovascular diseases
- • NA - 16 participants
- • In a single-blind, randomised, placebo-controlled crossover manner, this study aims to assess the impact of a high-fat mixed meal containing a whey protein (WP)-enriched milk fat globule membrane (MFGM) powdered ingredient on markers of heart and brain health in the fed state among middle-to-older-aged, postmenopausal women living with overweight and at moderate risk for cardiovascular disease
Who can take part?
- • Ages 50 Years to 75 Years
- • Diagnosed with cardiovascular diseases
- • Female only
Where?
- • Loughborough - Loughborough University
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
In a single-blind, randomised, placebo-controlled crossover manner, this study aims to assess the impact of a high-fat mixed meal containing a whey protein (WP)-enriched milk fat globule membrane (MFGM) powdered ingredient on markers of heart and brain health in the fed state among middle-to-older-aged, postmenopausal women living with overweight and at moderate risk for cardiovascular disease. Participants will attend two \~8 hour study visits, where they will consume a high-fat meal containing a WP-enriched MFGM powdered ingredient or a placebo WP-based powdered ingredient. Each visit will involve anthropometric measurements and periodic assessments of heart health, including blood pressure and blood vessel stiffness measurements, blood sample collections, as well as computer-based tests measuring mood and cognition (brain function) over a 6-hour postprandial period.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 50 Years - 75 Years
- Who can join: Female only
What the study is looking for
- ✓Apparently healthy postmenopausal women (not menstruating for 12 or more months)
- ✓Aged 50 - 75 years
- ✓BMI: 25 - 40 kg/m²
- ✓Moderate CVD risk
- ✓Recreationally active (\> 3 x 30 min moderate exercise per week)
Who cannot take part
- ✗Smoking (including vaping)
- ✗Diagnosed with cardiovascular disease or suffered myocardial infarction /stroke in the past twelve months
- ✗Early or premature menopause resulting from medical conditions or undergoing surgery
- ✗Hormone replacement therapy within last 6 months
- ✗Use of antidepressant or anti-anxiety medication if it has changed in the last three months or expected to change...
See the full criteria
Where Is This Study? (1 UK site)
Loughborough University
Loughborough LE11 3TU, United Kingdom
How to Get in Touch
Oonagh Markey, BSc, PhD
Sponsor contactCONTACT
Aishwarya Borkar, BSc, MSc
Sponsor contactCONTACT
